Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chortoglyphus arcuatus allergenic extract is a sterile solution prepared from the storage mite Chortoglyphus arcuatus, used for **diagnostic testing and allergen immunotherapy** in individuals with a history of IgE-mediated allergic symptoms upon exposure to this mite. Mechanistically, the extract works by inducing immune responses that modulate mast cell activation and reduce IgE-mediated hypersensitivity, aiding in both diagnosis (via skin testing) and treatment (via desensitization protocols) for conditions such as allergic rhinitis and asthma. The extract is typically produced from the whole mite (body) and may contain significant allergens; body extracts are generally considered more representative for immunodiagnostics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chortoglyphus arcuatus allergenic extract.